![PCE artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts124/v4/94/32/1a/94321aaa-4adf-3df2-4810-f996719b6b1e/mza_11695467358112480520.jpg/100x100bb.jpg)
Managing Influenza in the High-Risk Patient – Episode 2
PCE
English - August 19, 2021 15:28 - 14 minutes - 13.7 MB - ★★★★ - 6 ratingsCourses Education Science Life Sciences app education np education podcasts for credit app medicine pa education np medicine pa medicine ce podcasts app podcasts cme podcasts Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Managing Influenza in the High-Risk Patient – Episode 1
Effective influenza management during the COVID-19 pandemic requires a knowledge of emerging diagnostics, immunizations, and antiviral agents. The armamentarium for influenza treatment now includes multiple classes including neuraminidase inhibitors (eg, oseltamivir) and the polymerase acidic endonuclease inhibitor, baloxavir. In this podcast, Mary Knudtson, DNSc, NP, FAAN, asks questions from healthcare professionals to infectious disease expert, Michael G. Ison, MD, MS on timely, individualized influenza prevention and treatment. This activity is available for CE/CME credit. Claim your credit at pce.is/flu.